Cargando…

ErbB3 plays a key role in the early phase of establishment of resistance to BRAF and/or MEK inhibitors

Detalles Bibliográficos
Autores principales:	Fattore, Luigi, Malpicci, Debora, Marra, Emanuele, Camerlingo, Rosalba, Roscilli, Giuseppe, Belleudi, Francesca, Ribas, Antoni, Mancini, Rita, Torrisi, Maria Rosaria, Aurisicchio, Luigi, Ascierto, Paolo Antonio, Ciliberto, Gennaro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Keynote Speaker Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4315234/ http://dx.doi.org/10.1186/1479-5876-13-S1-K3

Ejemplares similares

Combination of antibodies directed against different ErbB3 surface epitopes prevents the establishment of resistance to BRAF/MEK inhibitors in melanoma
por: Fattore, Luigi, et al.
Publicado: (2015)

Activation of an early feedback survival loop involving phospho-ErbB3 is a general response of melanoma cells to RAF/MEK inhibition and is abrogated by anti-ErbB3 antibodies
por: Fattore, Luigi, et al.
Publicado: (2013)

Activation of the ErbB3-AKT axis promotes melanoma cell survival and proliferation in response to RAF/MEK inhibition
por: Fattore, Luigi, et al.
Publicado: (2014)

The promise of anti-ErbB3 monoclonals as new cancer therapeutics
por: Aurisicchio, Luigi, et al.
Publicado: (2012)

Combination therapy with anti-ErbB3 monoclonal antibodies and EGFR TKIs potently inhibits Non-small Cell Lung Cancer
por: Noto, Alessia, et al.
Publicado: (2013)

MEK + CDK4 a regimen for non-BRAF V6000 melanoma
por: Sosman, Jeff
Publicado: (2015)

Synergistic antitumor activity of histone deacetylase inhibitors and anti-ErbB3 antibody in NSCLC primary cultures via modulation of ErbB receptors expression
por: Ciardiello, Chiara, et al.
Publicado: (2016)

The immune-related role of BRAF in melanoma
por: Tomei, Sara, et al.
Publicado: (2015)

Combining targeted and immunotherapy: BRAF inhibitor dabrafenib (D) ± the MEK inhibitor trametinib (T) in combination with ipilimumab (Ipi) for V600E/K mutation-positive unresectable or metastatic melanoma (MM)
por: Puzanov, Igor
Publicado: (2015)

Grp94-specific monoclonal antibody to counteract BRAF inhibitor resistance in BRAF(V600E) melanoma
por: Sabbatino, F, et al.
Publicado: (2015)

Novel combination therapies for BRAF-mutant melanoma
por: McArthur, Grant A
Publicado: (2015)

ErbB3 Phosphorylation as Central Event in Adaptive Resistance to Targeted Therapy in Metastatic Melanoma: Early Detection in CTCs during Therapy and Insights into Regulation by Autocrine Neuregulin
por: Ruggiero, Ciro Francesco, et al.
Publicado: (2019)

Reverse transcriptase inhibition potentiates target therapy in BRAF-mutant melanomas: effects on cell proliferation, apoptosis, DNA-damage, ROS induction and mitochondrial membrane depolarization
por: Fattore, Luigi, et al.
Publicado: (2020)

On translating technology research into industrial applications
por: Wong, Stephen T C
Publicado: (2014)

TVET as an important factor in country’s economic development
por: Pavlova, Margarita
Publicado: (2014)

Assisted technology for daily living
por: Tong, Kai-yu Raymond
Publicado: (2014)

Inhibition of Stearoyl-CoA desaturase 1 reverts BRAF and MEK inhibition-induced selection of cancer stem cells in BRAF-mutated melanoma
por: Pisanu, Maria Elena, et al.
Publicado: (2018)

Are Genetic Vaccines the Right Weapon against COVID-19?
por: Conforti, Antonella, et al.
Publicado: (2020)

MicroRNAs in melanoma development and resistance to target therapy
por: Fattore, Luigi, et al.
Publicado: (2017)

Diabetes and the diabetic foot in 2011
por: Boulton, Andrew JM
Publicado: (2011)

Diagnosis and management of diabetic neuropathy
por: Boulton, Andrew JM
Publicado: (2011)

Shifting paradigms in the approach to footstrikes, footwear and treatment of the foot
por: Davis, Irene
Publicado: (2011)

Evaluation of the injured runner: developing the clinical hypothesis
por: Davis, Irene
Publicado: (2011)

Gait retraining: altering the fingerprint of gait
por: Davis, Irene
Publicado: (2011)

Why does gout target the foot? The pathogenesis of podagra
por: Roddy, Edward
Publicado: (2011)

Foot pain: common, of consequence, and consulted about
por: Roddy, Edward
Publicado: (2011)

Epidemiology and impact of hallux valgus: more than just bunions
por: Roddy, Edward
Publicado: (2011)

The legacy of Alex Stacoff for foot and footwear biomechanics research
por: Cavanagh, Peter R
Publicado: (2012)

Biomechanics of the ageing foot and ankle
por: Menz, Hylton B
Publicado: (2012)

In vivo, intrinsic kinematics of the foot and ankle
por: Arndt, Toni, et al.
Publicado: (2012)

An intelligent sport shoe to prevent ankle inversion sprain injury
por: Fong, Daniel TP
Publicado: (2012)

Rearfoot and forefoot footfall patterns: implications for barefoot running
por: Hamill, Joseph
Publicado: (2012)

How to build large, multi-scale, functional brain models
por: Eliasmith, Chris
Publicado: (2014)

Exploring cortex in a high-throughput manner by building brain observatories
por: Koch, Christof
Publicado: (2014)

Balancing and tight coupling: an approach to determine dynamic mechanisms of biological brain networks
por: Skinner, Frances K
Publicado: (2014)

Studying large-scale brain networks: electrical stimulation and neural-event-triggered fMRI
por: Logothetis, NK, et al.
Publicado: (2013)

The brain activity map: imaging the activity of entire neural circuits
por: Yuste, Rafael
Publicado: (2013)

The influence of metabolic energy on neural computation
por: Laughlin, Simon
Publicado: (2013)

Rescuing the spike
por: Denève, Sophie
Publicado: (2013)

Abstract Withdrawn
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_lsfukanhfeov285l1612ht5avv